Yvoire Hydro Regulatory Status: A Professional Sourcing Guide

Yvoire Hydro is a hyaluronic acid dermal filler manufactured by LG Chem, a South Korean chemical company with a significant presence in the medical aesthetics sector. Originating from South Korea, Yvoire Hydro is designed for specific aesthetic applications, presenting a distinct profile within the broader category of Hyaluronic acid dermal fillers. Its formulation is developed to meet professional requirements for handling and application.

LG Chem's commitment to research and development informs the production of its Yvoire range. For clinic owners and practitioners, understanding the manufacturer's background and product origin provides a foundational assurance regarding quality control and consistency. This includes adherence to manufacturing standards relevant to medical devices.

The regulatory landscape for aesthetic injectables is segmented, with different requirements across continents. For Yvoire Hydro, several key certifications define its market accessibility:

• KFDA (Korean Ministry of Food and Drug Safety): As a product of South Korea, Yvoire Hydro holds KFDA approval, indicating compliance with the stringent domestic regulatory framework for medical devices. This is a primary certification establishing its quality and safety standards in its country of origin.
• CE Mark: The Yvoire product line generally holds CE certification, which permits its commercialization within the European Economic Area (EEA) and the UK. [VERIFY: exact CE class and notified body for Yvoire Hydro]. This marking signifies conformity with EU health, safety, and environmental protection standards.
• FDA (U.S. Food and Drug Administration): [VERIFY: Yvoire Hydro FDA approval status for the US market]. Many Korean HA fillers are not directly FDA-approved for sale in the United States; professionals in the US should verify specific product approvals for their jurisdiction.
• GMP (Good Manufacturing Practice) & ISO Standards: LG Chem operates under strict GMP guidelines, ensuring products like Yvoire Hydro are consistently produced and controlled according to quality standards appropriate to their intended use. Compliance with ISO standards, such as ISO 13485 for medical devices, is also a common expectation, reflecting a robust quality management system.

With CE marking, Yvoire Hydro is generally eligible for distribution and use by qualified professionals within the European Union and the United Kingdom. This status simplifies the regulatory pathway for clinics and resellers in these regions. However, national regulations within EU member states or the UK may impose additional requirements concerning prescription status, professional qualifications for administration, and specific marketing guidelines. Always confirm local jurisdictional requirements for stocking and use.

Market access in the Gulf Cooperation Council (GCC) states, Latin America (LATAM), and the broader Asia-Pacific (APAC) region varies considerably. While CE marking or KFDA approval can serve as a basis for recognition, many countries in these regions require specific local registrations through their national health authorities. Sourcing professionals must verify that the product has obtained all necessary import licenses and local registrations for their target market. For example, some LATAM countries may accept CE certification, while others demand independent local clinical data and approval processes. Understanding these nuances is as critical as verifying product authenticity itself, similar to how professionals approach products like Sedy Fill Regulatory Status.

The global market for aesthetic injectables often features parallel import channels. While legally permissible in some jurisdictions, parallel imports can complicate traceability and product authenticity verification. For professionals, it is paramount to source Yvoire Hydro exclusively from authorized distributors or reputable wholesalers. This ensures not only compliance but also access to legitimate product batches with clear traceability. Demanding comprehensive documentation from suppliers is a non-negotiable step to mitigate risks associated with counterfeit products or those stored outside recommended cold chain parameters.

Understanding the wholesale pricing structure for Yvoire Hydro is essential for clinic owners and resellers to manage inventory costs and profitability. The illustrative wholesale price for Yvoire Hydro is $69.8 per unit. Volume-based tier discounts are typically offered to professional buyers to incentivize larger orders:

• 11 units: 4% discount
• 21 units: 5% discount
• 31 units: 6% discount
• 51+ units: 8% discount

These structures are designed to support clinics by providing cost efficiencies as order volumes increase. Professionals can review similar pricing models and their implications for clinic economics, as discussed in guides such as the LEXYAL Wholesale Price article.

When sourcing Yvoire Hydro, professionals should demand clear evidence of regulatory compliance and product legitimacy. This includes:

• Certificate of Authenticity (COA): A document confirming the product's origin and genuine manufacturer.
• Batch Number & Expiry Date: Clearly printed on all packaging, traceable to the manufacturer.
• Cold Chain Documentation: Proof of appropriate temperature-controlled transport and storage, crucial for HA fillers.
• Import/Export Licenses: Relevant documentation demonstrating legal cross-border movement.
• Regulatory Approvals: Copies of KFDA, CE Mark certificates, or specific national approvals pertinent to your region.

Rigorous supplier vetting is fundamental to maintaining professional standards and patient safety.